Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer

Journal of Urology

Volumn 175, Issue 4, 2006, Pages 1298-1303

  Freedland, Stephen J ^a,i   Kane, Christopher J ^b,c   Amling, Christopher L ^d   Aronson, William J ^e   Presti Jr , Joseph C ^f,g   Terris, Martha K ^h  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biopsy; Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; GLEASON SCORE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; THERAPY DELAY; TUMOR BIOPSY;

EID: 33644583596     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00646-4     Document Type: Article

References (15)

1. R.K. Nam, M.A. Jewett, M.D. Krahn, M.A. Robinette, J. Tsihlias, A. Toi Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy Can J Urol 10 2003 1891
2. M.A. Khan, L.A. Mangold, J.I. Epstein, J.K. Boitnott, P.C. Walsh, A.W. Partin Impact of surgical delay on long-term cancer control for clinically localized prostate cancer J Urol 172 2004 1835
3. A. Shibata, U.M. Mohanasundaram, M.K. Terris Time interval from prostate biopsy to radical prostatectomy effect on PSA, Gleason sum, and risk of recurrence Urology 66 2005 808
4. S.J. Freedland, C.L. Amling, F. Dorey, C.J. Kane, J.C. Presti Jr, M.K. Terris Race as an outcome predictor after radical prostatectomy results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database Urology 60 2002 670
5. A.V. D'Amico, R. Whittington, S.B. Malkowicz, D. Schultz, K. Blank, G.A. Broderick Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
6. S.J. Freedland, M.E. Sutter, F. Dorey, W.J. Aronson Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen Urology 61 2003 365
7. S.J. Freedland, W.J. Aronson, M.K. Terris, C.J. Kane, C.L. Amling, F. Dorey Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy results from SEARCH database J Urol 169 2003 2136
8. A. Khatami, J.E. Damber, P. Lodding, C.G. Pihl, J. Hugosson Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy? - A case control study Scand J Urol Nephrol 37 2003 213
9. H.B. Carter, P.C. Walsh, P. Landis, J.I. Epstein Expectant management of nonpalpable prostate cancer with curative intent preliminary results J Urol 167 2002 1231
10. S.W. Melchior, E. Corey, W.J. Ellis, A.A. Ross, T.J. Layton, M.M. Oswin Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate Clin Cancer Res 3 1997 249
11. C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, P.C. Walsh Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
12. A. Patel, F. Dorey, J. Franklin, J.B. deKernion Recurrence patterns after radical retropubic prostatectomy clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen J Urol 158 1997 1441
13. S.J. Freedland, E.B. Humphreys, L.A. Mangold, M. Eisenberger, F.J. Dorey, P.C. Walsh Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433
14. A.V. D'Amico, J.W. Moul, P.R. Carroll, L. Sun, D. Lubeck, M.H. Chen Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Natl Cancer Inst 95 2003 1376
15. J.F. Ward, M.L. Blute, J. Slezak, E.J. Bergstralh, H. Zincke The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy J Urol 170 2003 1872